# Open-label Safety & Efficacy of ZS (Sodium Zirconium Cyclosilicate)10g qd to Extend Study ZS-004 in Hyperkalemia.

> **NCT02107092** · PHASE3 · COMPLETED · sponsor: **ZS Pharma, Inc.** · enrollment: 123 (actual)

## Conditions studied

- Hyperkalemia

## Interventions

- **DRUG:** Sodium Zirconium Cyclosilicate

## Key facts

- **NCT ID:** NCT02107092
- **Lead sponsor:** ZS Pharma, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-05-31
- **Primary completion:** 2015-07-31
- **Final completion:** 2015-08-31
- **Target enrollment:** 123 (ACTUAL)
- **Last updated:** 2018-08-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02107092

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02107092, "Open-label Safety & Efficacy of ZS (Sodium Zirconium Cyclosilicate)10g qd to Extend Study ZS-004 in Hyperkalemia.". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02107092. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*